(i) As long as CKD treatment was independent of the underlying pathogenesis and mainly based on optimized metabolic and blood pressure control as well as the inhibition of the renin–angiotensin–aldosterone system—which is used to reduce cardiovascular complications in the CKD population in any case—no further therapeutic consequences resulted from histologic work-up [19, 37]. Here, REN is linked to chronic kidney disease.